等级
pharmaceutical primary standard
API类
galactose
制造商/商品名称
USP
应用
pharmaceutical (small molecule)
格式
neat
InChI
1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3+,4+,5-,6+/m1/s1
InChI key
WQZGKKKJIJFFOK-PHYPRBDBSA-N
一般描述
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
Galactose contains d-galactopyranose (C6H12O6), which is obtained either as one of the products of the metabolism of lactose, a naturally occurring sugar in dairy products, by the digestive enzyme lactase, or from arabinogalactans isolated from a plant-derived source.
Galactose contains d-galactopyranose (C6H12O6), which is obtained either as one of the products of the metabolism of lactose, a naturally occurring sugar in dairy products, by the digestive enzyme lactase, or from arabinogalactans isolated from a plant-derived source.
应用
Galactose USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:
- Guar Gum
- Lactulose Concentrate
- Lactulose Solution
- Ganoderma Lucidum Fruiting Body Powder
- Ganoderma Lucidum Fruiting Body
分析说明
These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
其他说明
Sales restrictions may apply.
储存分类代码
11 - Combustible Solids
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
法规信息
监管及禁止进口产品
Lactulose Concentrate
United States Pharmacopeia and National Formulary
United States Pharmacopeia, 40(5), 2521-2521 (2016)
Ganoderma Lucidum Fruiting Body Powder
United States Pharmacopeia and National Formulary
United States Pharmacopeia, 40(5), 5008-5008 (2015)
Guar Gum
United States Pharmacopeia and National Formulary
United States Pharmacopeia, 41(2), 5813-5813 (2018)
Galactose
United States Pharmacopeia and National Formulary
United States Pharmacopeia, 44(5) (2020)
Michelle P Christie et al.
PloS one, 9(4), e95024-e95024 (2014-04-17)
Glycosylation of biopharmaceuticals can mediate cell specific delivery by targeting carbohydrate receptors. Additionally, glycosylation can improve the physico-chemical (drug-like) properties of peptide based drug candidates. The main purpose of this study was to examine if glycosylation of the peptide enkephalin
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门